An alternative approach to understanding the pathophysiological mechanisms of chronic heart failure

David H MacIver1, Mark J Dayer

  • 1Department of Cardiology, Taunton & Somerset Hospital, Musgrove Park, Taunton, Somerset, TA1 5DA, UK. david.maciver@tst.nhs.uk

Insights

A unified hypothesis for heart failure proposes a common pathway. Chronic heart failure involves regulating ventricular end-diastolic volume to maintain tissue perfusion and cardiac output.

Area of Science:

  • Cardiology
  • Physiology
  • Pathophysiology

Background:

  • Current heart failure definitions lack universal applicability and exclusivity.
  • The pathogenesis of heart failure is complex, involving multiple implicated pathophysiological processes.
  • Clinical and neurohumoral features may depend more on severity and onset speed than etiology.

Purpose of the Study:

  • To propose a simplified definition and unifying hypothesis for chronic heart failure pathogenesis.
  • To present an alternative framework based on myocardial mechanics and energetics.
  • To encourage a comprehensive and unambiguous understanding of heart failure mechanisms.

Main Methods:

  • Utilizing a framework of myocardial mechanics and energetics.
  • Analyzing the determinants of cardiac output, stroke volume, and ejection fraction.
  • Proposing regulation of ventricular end-diastolic volume as a dominant compensatory mechanism.

Main Results:

  • Chronic heart failure can be understood through myocardial mechanics and energetics.
  • Ventricular end-diastolic volume regulation is a key compensatory mechanism.
  • This mechanism normalizes stroke volume and tissue perfusion during falls in perfusion.

Conclusions:

  • A unifying hypothesis for heart failure pathogenesis is proposed.
  • This hypothesis simplifies understanding by focusing on myocardial mechanics and energetics.
  • A common pathway involving ventricular end-diastolic volume regulation is suggested for all heart failure forms.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...